Positive orphan drug opinion supports SOM3355’s potential as first-line treatment in Europe
News
Capvaxive shows strong immune response in children at risk of pneumococcal disease
Merck presents phase 3 STRIDE-13 trial results at ESCMID conference in Lisbon
Lundbeck unveils migraine data for eptinezumab at international congress
New phase 4 results show sustained symptom relief and improved patient outcomes
Rezatapopt shows promise in phase 2 trial for TP53 Y220C solid tumours
Early data reveals strong response rates in ovarian cancer cohort
Quotient Sciences and CPI launch RNA drug development venture
New partnership aims to fast-track mRNA therapies from lab to clinic
Bluejay begins phase 3 trial of brelovitug for hepatitis D
First patient enrolled in AZURE-2 study comparing brelovitug to Hepcludex
Eisai unveils promising phase 1b data for narcolepsy drug E2086
Novel orexin receptor agonist shows potential to improve wakefulness
AlzeCure presents phase 2 data on ACD440 at NeuPSIG 2025
Topical TRPV1 antagonist shows promise in heat-induced neuropathic pain
Resolution Therapeutics doses first patient in EMERALD study of RTX001
Trial explores regenerative macrophage therapy for liver disease
eXmoor and Anthony Nolan partner to streamline cell therapy development
Collaboration offers end-to-end support from donor sourcing to manufacturing
FDA approves LEQEMBI IQLIK for maintenance dosing in early Alzheimer’s disease
New subcutaneous autoinjector offers at-home treatment option for patients
Lilly receives UK approval for pirtobrutinib in relapsed blood cancers
MHRA grants conditional authorisation for treatment targeting mantle cell lymphoma
Akiram advances trial of targeted radiotherapy for solid tumours
Swedish biotech company Akiram Therapeutics has announced significant progress in its first clinical trial of AKIR001,...
Coya Therapeutics to progress trial of ALS treatment upon FDA approval
The US Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application from Coya...
Encare’s ERAS system gains Mayo Clinic qualification, strengthening global reach
Encare’s ERAS Interactive Audit System (EIAS) has earned qualification on the Mayo Clinic Platform_Solutions Studio –...
